Subscribe
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
Pulmonary Rehab in COPD: Mental Health & CV Considerations
AHA 2019: 11 Late Breaking Clinical Trials At-a-Glance
ISCHEMIA: Initial Revascularization Did Not Reduce Adverse CV Outcomes in SIHD
EVAPORATE: Icosapent Ethyl Added to Statins Slowed Coronary Atherosclerosis Progression
Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH
June 15, 2026
Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD
June 17-19, 2026
Seth A. Wander, MD, PhD; Kate Baxstrom, MD
Richard Bedlack, MD, PhD
June 23, 2026
1 Session is Available!
Terry Heiman-Patterson, MD
Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA
Selina R. McGee, OD, FAAO
Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; John Hovanesian, MD, FACS
Seth A. Wander, MD, PhD; Yang Liu, MD
Yelda Nouri, MD; Sara Nunnery, MD, MSCI
July 10-11, 2026
Rachel N. Grisham, MD; Ramez N. Eskander, MD; Oladapo Yeku, MD, PhD